Summary

Organization name

Profile

Sanofi-Aventis is one of the world's leading pharmaceutical companies and number 1 in Europe. 

Their focus is on 7 major therapeutic areas :

Cardiovascular

• Arterial hypertension
• Atrial fibrillation
• Peripheral arterial disease
• Heart failure
• Atherosclerosis/Restenosis
• Angina  

Thrombosis

• Arterial or venous thrombosis
• Deep venous thrombosis, complicated or not by pulmonary embolism
• Acute coronary syndromes (angina, myocardial infarction)
• Atherothrombosis

Metabolic disorders

• Diabetes type 1 and 2
• Dyslipidemia
• Hypercholesterolemia
• Obesity
• Cardiometabolic risks

Oncology

• Colorectal cancer
• Gastric cancer
• Head and neck cancer
• Prostate cancer
• Breast cancer
• Non-small cell lung cancer (NSCLC)
• Melanoma
• Malignant hemopathies (leukemias)

Central Nervous System

• Sleep disorders
• Neurogenic pain
• Alzheimer's disease
• Parkinson's disease
• Multiple Sclerosis
• Schizophrenia and bipolar disorders
• Amyotrophic lateral sclerosis
• Anxiety
• Depression
• Nicotine withdrawal  

Internal medicine

• Bacterial, viral and parasitic infections
• Rheumatoid arthritis
• Urology
• Osteoporosis
• Pain
• Chronic obstructive pulmonary disease (COPD)
• Allergy
• Inflammation
• Urinary incontinence    

Vaccines

• please check additional profile

Sanofi-Aventis research focuses on the development of new approaches, new targets, new pharmaceutical classes. For example, with the central nervous system, the objective is not just to identify new psychotropic drugs to treat depression, schizophrenia and anxiety, but also to develop neuroprotective agents. In other words to propose causal, not symptomatic, therapeutic solutions.

However, innovation in health is not limited to the discovery of new medications. It can also involve developing a new formulation of an existing drug to provide patients with a better quality of life (easier and less frequent administration, reduced side effects...).

To ensure patients receive the most effective treatment, in the shortest possible time, several research strategies are pursued in parallel for each of the therapeutic areas. These can include :

• new therapeutic indications
• new formulations
• molecular, physiopathological and exploratory approaches
• biotechnology, genomics and proteomics.

Contact data and additional information are provided online.

URL

Your feedback

back